NCT06044818Completed
Validation of Accexible as a Tool for Screening and Monitoring Depression.
Validación Del Sistema de Cribaje y Seguimiento de acceXible Para depresión.
Source: ClinicalTrials.gov · Last updated 25 Mar 2026
Brief summary (registry, in English)
Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 166 (actual)
- First submitted
- 13 Jul 2023
- Start date
- 10 Jul 2023
- Primary completion date
- 17 Apr 2025
- Lead sponsor
- Accexible
- Diseases
- Depression
- NCT number
- NCT06044818
What you commit to
- Study type: Observational
- Participants enrolled: 166
- From 10 Jul 2023 to the primary completion date, 17 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- To have received a diagnosis of neurodegeneration.
Other
- To have significant vision problems that would affect the ability to perceive visual stimuli.
- To have significant hearing problems that would affect the ability to understand verbal cues.
- To be unable to give informed consent to participate in the study.
Who the study is looking for
- Adult 18-65 years of age.
- Participants must have Spanish as their first language (able to speak and understand verbal messages).
- Participants must have mobile phone with internet.
- Participants must have the ability to understand AcceXible's basic instructions.
- Participants must agree to participate in the study and have voluntarily signed the informed consent.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vall d'Hebron Institut de Investigación (VHIR) Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.